Literature DB >> 23324406

Phthalazinone inhibitors of inosine-5'-monophosphate dehydrogenase from Cryptosporidium parvum.

Corey R Johnson1, Suresh Kumar Gorla, Mandapati Kavitha, Minjia Zhang, Xiaoping Liu, Boris Striepen, Jan R Mead, Gregory D Cuny, Lizbeth Hedstrom.   

Abstract

Cryptosporidium parvum (Cp) is a potential biowarfare agent and major cause of diarrhea and malnutrition. This protozoan parasite relies on inosine 5'-monophosphate dehydrogenase (IMPDH) for the production of guanine nucleotides. A CpIMPDH-selective N-aryl-3,4-dihydro-3-methyl-4-oxo-1-phthalazineacetamide inhibitor was previously identified in a high throughput screening campaign. Herein we report a structure-activity relationship study for the phthalazinone-based series that resulted in the discovery of benzofuranamide analogs that exhibit low nanomolar inhibition of CpIMPDH. In addition, the antiparasitic activity of select analogs in a Toxoplasma gondii model of C. parvum infection is also presented.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23324406      PMCID: PMC3557747          DOI: 10.1016/j.bmcl.2012.12.037

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  17 in total

Review 1.  IMP dehydrogenase: structure, mechanism, and inhibition.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

2.  Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO mice.

Authors:  H N Ehigiator; P Romagnoli; K Borgelt; M Fernandez; N McNair; W E Secor; J R Mead
Journal:  Parasite Immunol       Date:  2005 Jan-Feb       Impact factor: 2.280

Review 3.  An updated review on Cryptosporidium and Giardia.

Authors:  David B Huang; A Clinton White
Journal:  Gastroenterol Clin North Am       Date:  2006-06       Impact factor: 3.806

4.  Genetic complementation in apicomplexan parasites.

Authors:  Boris Striepen; Michael W White; Catherine Li; Michael N Guerini; S-Banoo Malik; John M Logsdon; Chang Liu; Mitchell S Abrahamsen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

5.  The genome of Cryptosporidium hominis.

Authors:  Ping Xu; Giovanni Widmer; Yingping Wang; Luiz S Ozaki; Joao M Alves; Myrna G Serrano; Daniela Puiu; Patricio Manque; Donna Akiyoshi; Aaron J Mackey; William R Pearson; Paul H Dear; Alan T Bankier; Darrell L Peterson; Mitchell S Abrahamsen; Vivek Kapur; Saul Tzipori; Gregory A Buck
Journal:  Nature       Date:  2004-10-28       Impact factor: 49.962

6.  Gene transfer in the evolution of parasite nucleotide biosynthesis.

Authors:  Boris Striepen; Andrea J P Pruijssers; Jinling Huang; Catherine Li; Marc-Jan Gubbels; Nwakaso N Umejiego; Lizbeth Hedstrom; Jessica C Kissinger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design.

Authors:  Nwakaso N Umejiego; Catherine Li; Thomas Riera; Lizbeth Hedstrom; Boris Striepen
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

8.  Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis.

Authors:  Nwakaso N Umejiego; Deviprasad Gollapalli; Lisa Sharling; Anna Volftsun; Jennifer Lu; Nicole N Benjamin; Adam H Stroupe; Thomas V Riera; Boris Striepen; Lizbeth Hedstrom
Journal:  Chem Biol       Date:  2008-01

9.  Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congeners.

Authors:  B L Mylari; E R Larson; T A Beyer; W J Zembrowski; C E Aldinger; M F Dee; T W Siegel; D H Singleton
Journal:  J Med Chem       Date:  1991-01       Impact factor: 7.446

10.  Complete genome sequence of the apicomplexan, Cryptosporidium parvum.

Authors:  Mitchell S Abrahamsen; Thomas J Templeton; Shinichiro Enomoto; Juan E Abrahante; Guan Zhu; Cheryl A Lancto; Mingqi Deng; Chang Liu; Giovanni Widmer; Saul Tzipori; Gregory A Buck; Ping Xu; Alan T Bankier; Paul H Dear; Bernard A Konfortov; Helen F Spriggs; Lakshminarayan Iyer; Vivek Anantharaman; L Aravind; Vivek Kapur
Journal:  Science       Date:  2004-03-25       Impact factor: 47.728

View more
  17 in total

1.  Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis.

Authors:  Suresh Kumar Gorla; Nina N McNair; Guangyi Yang; Song Gao; Ming Hu; Venkatakrishna R Jala; Bodduluri Haribabu; Boris Striepen; Gregory D Cuny; Jan R Mead; Lizbeth Hedstrom
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

2.  Benzoxazoles, Phthalazinones, and Arylurea-Based Compounds with IMP Dehydrogenase-Independent Antibacterial Activity against Francisella tularensis.

Authors:  Suresh Kumar Gorla; Yan Zhang; Meaghan M Rabideau; Aiping Qin; Shibin Chacko; Amanda L House; Corey R Johnson; Kavitha Mandapati; Hannah M Bernstein; Elizabeth S McKenney; Helena Boshoff; Minjia Zhang; Ian J Glomski; Joanna B Goldberg; Gregory D Cuny; Barbara J Mann; Lizbeth Hedstrom
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

3.  Repurposing cryptosporidium inosine 5'-monophosphate dehydrogenase inhibitors as potential antibacterial agents.

Authors:  Kavitha Mandapati; Suresh Kumar Gorla; Amanda L House; Elizabeth S McKenney; Minjia Zhang; Suraj Nagendra Rao; Deviprasad R Gollapalli; Barbara J Mann; Joanna B Goldberg; Gregory D Cuny; Ian J Glomski; Lizbeth Hedstrom
Journal:  ACS Med Chem Lett       Date:  2014-06-10       Impact factor: 4.345

4.  A survey study on gastrointestinal parasites of stray cats in Azarshahr, (East Azerbaijan province, Iran).

Authors:  Nasser Hajipour; Aabbas Imani Baran; Mohammad Yakhchali; Seyed Mehdi Banan Khojasteh; Farzam Sheikhzade Hesari; Bijan Esmaeilnejad; Jafar Arjmand
Journal:  J Parasit Dis       Date:  2015-02-28

5.  A probable means to an end: exploring P131 pharmacophoric scaffold to identify potential inhibitors of Cryptosporidium parvum inosine monophosphate dehydrogenase.

Authors:  Kehinde F Omolabi; Emmanuel A Iwuchukwu; Clement Agoni; Fisayo A Olotu; Mahmoud E S Soliman
Journal:  J Mol Model       Date:  2021-01-09       Impact factor: 1.810

Review 6.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

7.  Inhibition of Inosine-5'-monophosphate Dehydrogenase from Bacillus anthracis: Mechanism Revealed by Pre-Steady-State Kinetics.

Authors:  Yang Wei; Petr Kuzmič; Runhan Yu; Gyan Modi; Lizbeth Hedstrom
Journal:  Biochemistry       Date:  2016-09-02       Impact factor: 3.162

8.  Optimization of benzoxazole-based inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.

Authors:  Suresh Kumar Gorla; Mandapati Kavitha; Minjia Zhang; James En Wai Chin; Xiaoping Liu; Boris Striepen; Magdalena Makowska-Grzyska; Youngchang Kim; Andrzej Joachimiak; Lizbeth Hedstrom; Gregory D Cuny
Journal:  J Med Chem       Date:  2013-05-13       Impact factor: 7.446

9.  Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure-Activity As Potential Antituberculosis Agents.

Authors:  Shibin Chacko; Helena I M Boshoff; Vinayak Singh; Davide M Ferraris; Deviprasad R Gollapalli; Minjia Zhang; Ann P Lawson; Michael J Pepi; Andrzej Joachimiak; Menico Rizzi; Valerie Mizrahi; Gregory D Cuny; Lizbeth Hedstrom
Journal:  J Med Chem       Date:  2018-05-30       Impact factor: 7.446

10.  Mycophenolic anilides as broad specificity inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors.

Authors:  Seungheon Lee; Angela F Ku; Mohana Rao Vippila; Yong Wang; Minjia Zhang; Xingyou Wang; Lizbeth Hedstrom; Gregory D Cuny
Journal:  Bioorg Med Chem Lett       Date:  2020-09-12       Impact factor: 2.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.